<DOC>
	<DOCNO>NCT01475032</DOCNO>
	<brief_summary>The purpose study demonstrate CHF 1535 pressurize meter dose inhaler ( pMDI ) non-inferior correspond dose free combination Beclomethasone ( BDP ) Formoterol Fumarate ( FF ) superior correspond dose BDP term lung function asthmatic child patient .</brief_summary>
	<brief_title>Efficacy Study Product `` CHF 1535 '' Versus Beclomethasone ( BDP ) Free Combo Asthmatic Children</brief_title>
	<detailed_description />
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<criteria>Male female child ( age ≥ 5 &lt; 12 year ) Partly control asthma child accord Global Initiative Asthma guideline ( GINA ) Symptomatic asthmatic patient treat BDP 400 microgram equivalent FEV1 ≥ 60 % ≤ 95 % predict normal value Patients two admission hospital asthma exacerbation past 12 month admission intensive care ever . Occurrence acute asthma exacerbation low respiratory tract infection 4 week study entry History near fatal asthma History cystic fibrosis , bronchiectasis primary ciliary dyskinesia Diagnosis restrictive lung disease . Patients treat systemic corticosteroid Significant medical history and/or treatment</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Asthma</keyword>
	<keyword>child</keyword>
	<keyword>chronic treatment</keyword>
</DOC>